| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |